Robert Weinberg
| Robert Weinberg | |
|---|---|
| Born | Robert Allan Weinberg November 11, 1942 Pittsburgh |
| Nationality | American |
| Fields | Molecular Biology, Oncology, and Genetics |
| Institutions | |
| Alma mater | MIT (Ph.D) |
| Doctoral students | |
| Known for |
|
| Notable awards | |
|
Website weinberglab |
|
Robert Allan Weinberg (born November 11, 1942) is a biologist, Daniel K. Ludwig Professor for Cancer Research at Massachusetts Institute of Technology (MIT), director of the Ludwig Center of the MIT, and American Cancer Society Research Professor. His research is in the area of oncogenes and the genetic basis of human cancer.
Robert Weinberg is also affiliated with the Broad Institute and is a founding member of the Whitehead Institute for Biomedical Research. He teaches at MIT including course 7.012 (introductory biology) with Eric Lander. Weinberg and Lander are among the co-founders of Verastem, which is a biopharmaceutical company focused on discovering and developing drugs to treat cancer by targeting cancer stem cells.
He is best known for his discoveries of the first human oncogene Ras and the first tumor suppressor gene Rbp. 371-381, which is partially documented in Natalie Angier′s book, Natural Obsessions, about her year spent in Weinberg's lab.
In the late 20th century, advances in genetics led to the discovery of over one hundred cancer cell types. Cancer cells were noted for their bewildering diversity. It was hard to identify the principles that cancers had in common.
He and Douglas Hanahan wrote the seminal paper, "The Hallmarks of Cancer", published in January 2000, that gave the six requirements for one renegade cell to cause a deadly cancer: In 2011, they published an updated review article entitled "Hallmarks of cancer: the next generation".
...
Wikipedia